Cargando…

Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation

Atrial fibrillation (AF) is associated with an increased risk of ischemic stroke or systemic embolism compared with normal sinus rhythm. These strokes may efficiently be prevented in patients with risk factors using oral anticoagulant therapy, with either vitamin K antagonists (VKAs) or non-vitamin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bisson, Arnaud, Angoulvant, Denis, Philippart, Raphael, Clementy, Nicolas, Babuty, Dominique, Fauchier, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487882/ https://www.ncbi.nlm.nih.gov/pubmed/28493056 http://dx.doi.org/10.1007/s12325-017-0550-7

Ejemplares similares

Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications
por: Clementy, Nicolas, et al.
Publicado: (2018)

Prognosis in Familial Atrial Fibrillation
por: Fauchier, Laurent, et al.
Publicado: (2016)

Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis
por: Fauchier, Laurent, et al.
Publicado: (2020)

Benefits of an early management of palpitations
por: Clementy, Nicolas, et al.
Publicado: (2018)

Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure
por: Clementy, Nicolas, et al.
Publicado: (2018)

Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation
por: Clementy, Nicolas, et al.
Publicado: (2016)

Leadless or Conventional Transvenous Ventricular Permanent Pacemakers: A Nationwide Matched Control Study
por: Bodin, Alexandre, et al.
Publicado: (2022)

Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis
por: Bisson, Arnaud, et al.
Publicado: (2021)

Localization of Left Ventricular Lead Electrodes in Relation to Myocardial Scar in Patients Undergoing Cardiac Resynchronization Therapy
por: Bisson, Arnaud, et al.
Publicado: (2018)

Unexpected low prevalence of atrial fibrillation in cryptogenic ischemic stroke: a prospective study
por: Dion, Fanny, et al.
Publicado: (2010)

The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy
por: Clementy, Nicolas, et al.
Publicado: (2021)

Atrioventricular Nodal Reentrant Tachycardia Ablation Using Mini-Electrode Recordings
por: Clementy, Nicolas, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions
por: Fauchier, Laurent, et al.
Publicado: (2023)

Galectin-3 predicts response and outcomes after cardiac resynchronization therapy
por: Andre, Clémentine, et al.
Publicado: (2018)

Pacemaker Implantation After Balloon‐ or Self‐Expandable Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis
por: Bisson, Arnaud, et al.
Publicado: (2020)

Yearly Incidence of Stroke and Bleeding in Atrial Fibrillation with Concomitant Hyperthyroidism: A National Discharge Database Study
por: Zhang, Juqian, et al.
Publicado: (2022)

Atrial Fibrillation Associated with Heart Failure: Perspectives from Recent Large Clinical Studies and Translational Research
por: Bentounes, Sid Ahmed, et al.
Publicado: (2023)

Geographic Variations in the Quality of Oral Anticoagulation With Vitamin K Antagonists in the Era of New Anticoagulants
por: Fauchier, Laurent, et al.
Publicado: (2013)

Anodal Capture for Multisite Pacing with a Quadripolar Left Ventricular Lead: A Feasibility Study
por: Bodin, Alexandre, et al.
Publicado: (2021)

Left Purkinje premature ventricular complexes following left bundle branch area pacing
por: Lenormand, Thibault, et al.
Publicado: (2022)

Outcomes associated with sodium glucose co-transporter 2 inhibitors in anticoagulated atrial fibrillation patients
por: Fawzy, A M, et al.
Publicado: (2023)

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
por: Coleman, Craig I., et al.
Publicado: (2019)

Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Incomplete recovery of mechanical and endocrine left atrial functions one month after electrical cardioversion for persistent atrial fibrillation: a pilot study
por: Bernard-Brunet, Anne, et al.
Publicado: (2014)

Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France
por: Bowrin, Kevin, et al.
Publicado: (2020)

Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants
por: Bang, Oh Young, et al.
Publicado: (2016)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
por: Caturano, Alfredo, et al.
Publicado: (2019)

Prediction of early death after atrial fibrillation diagnosis: a french nationwide study
por: Bisson, A, et al.
Publicado: (2023)

Season of Birth and Cardiovascular Mortality in Atrial Fibrillation: A Population-Based Cohort Study
por: Gue, Ying X., et al.
Publicado: (2021)

Anticoagulation Control in Different Ethnic Groups Receiving Vitamin K Antagonist for Stroke Prevention in Atrial Fibrillation
por: Zawawi, Nur Azyyati, et al.
Publicado: (2021)

Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention
por: Zulkifly, Hanis, et al.
Publicado: (2022)

Atrial Fibrillation and the Risk of Ventricular Arrhythmias and Cardiac Arrest: A Nationwide Population-Based Study
por: Fawzy, Ameenathul M., et al.
Publicado: (2023)

Special considerations for therapeutic choice of non–vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation
por: Okumura, Ken, et al.
Publicado: (2016)

Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation
por: Seiffge, David J., et al.
Publicado: (2019)

Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?
por: Hammwöhner, Matthias, et al.
Publicado: (2020)

Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in secondary stroke and systemic embolism prevention
por: Gorczyca, Iwona, et al.
Publicado: (2019)

Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
por: Undas, Anetta, et al.
Publicado: (2020)

Acute pathophysiological myocardial changes following intra-cardiac electrical shocks using a proteomic approach in a sheep model
por: Bodin, Alexandre, et al.
Publicado: (2020)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
por: Peeters, Frederique E. C. M., et al.
Publicado: (2018)

Association of Vitamin K and Non‐Vitamin K Oral Anticoagulant Use and Cancer Incidence in Atrial Fibrillation Patients
por: Iftimi, Adina A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cmgucipger49687mnmuhj3hbej